SG11201602888SA - Topical anti-inflammatory pharmaceutical composition with zileuton cream formulation - Google Patents
Topical anti-inflammatory pharmaceutical composition with zileuton cream formulationInfo
- Publication number
- SG11201602888SA SG11201602888SA SG11201602888SA SG11201602888SA SG11201602888SA SG 11201602888S A SG11201602888S A SG 11201602888SA SG 11201602888S A SG11201602888S A SG 11201602888SA SG 11201602888S A SG11201602888S A SG 11201602888SA SG 11201602888S A SG11201602888S A SG 11201602888SA
- Authority
- SG
- Singapore
- Prior art keywords
- pharmaceutical composition
- cream formulation
- topical anti
- inflammatory pharmaceutical
- zileuton cream
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020130130165A KR101462474B1 (en) | 2013-10-30 | 2013-10-30 | Topical anti-inflammatory pharmaceutical formulation of cream formulation comprising zileuton |
| PCT/KR2014/007525 WO2015064898A1 (en) | 2013-10-30 | 2014-08-13 | Topical anti-inflammatory pharmaceutical composition with zileuton cream formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201602888SA true SG11201602888SA (en) | 2016-05-30 |
Family
ID=52290736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201602888SA SG11201602888SA (en) | 2013-10-30 | 2014-08-13 | Topical anti-inflammatory pharmaceutical composition with zileuton cream formulation |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9655841B2 (en) |
| EP (1) | EP3064197B1 (en) |
| JP (1) | JP6159885B2 (en) |
| KR (1) | KR101462474B1 (en) |
| CN (1) | CN105658202B (en) |
| AU (1) | AU2014341014B2 (en) |
| BR (1) | BR112016009777B1 (en) |
| CA (1) | CA2907060C (en) |
| DK (1) | DK3064197T3 (en) |
| ES (1) | ES2688469T3 (en) |
| HK (1) | HK1223568A1 (en) |
| HU (1) | HUE039408T2 (en) |
| PH (1) | PH12016500726A1 (en) |
| RU (1) | RU2616254C1 (en) |
| SG (1) | SG11201602888SA (en) |
| WO (1) | WO2015064898A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9855243B2 (en) * | 2013-10-30 | 2018-01-02 | Qurient Co., Ltd. | Topical anti-inflammatory pharmaceutical composition with zileuton cream formulation |
| JOP20210029A1 (en) * | 2018-08-16 | 2021-02-14 | Dr Reddys Laboratories Ltd | Topical oleaginous compositions |
| WO2021121645A1 (en) | 2019-12-20 | 2021-06-24 | Qurient Co., Ltd. | A topical anti-inflammatory pharmaceutical composition comprising zileuton |
| KR20230080579A (en) | 2021-11-30 | 2023-06-07 | 한국원자력의학원 | Pharmaceutical composition for treating or preventing cutaneous radiation syndromes comprising zileuton as an active ingredient |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050090553A1 (en) * | 1992-06-30 | 2005-04-28 | Shapiro Howard K. | Compositions and method for treatment of chronic inflammatory diseases |
| ES2244966T3 (en) * | 1994-12-12 | 2005-12-16 | Omeros Corporation | IRRIGATION SOLUTION AND ITS USE TO PERIOPERATORY INHIBIT THE PAIN, INFLAMMATION AND SPASM IN A WOUND. |
| US6656928B1 (en) * | 1999-09-02 | 2003-12-02 | Mccadden Michael E. | Composition for the topical treatment of rashes, dermatoses and lesions |
| GB0108498D0 (en) * | 2001-04-04 | 2001-05-23 | Novartis Ag | Organic Compounds |
| DE10121252A1 (en) * | 2001-04-30 | 2002-11-07 | Christos C Zouboulis | Acne treatment |
| CA2628630A1 (en) * | 2005-11-15 | 2007-05-24 | Baxter International Inc. | Compositions of lipoxygenase inhibitors |
| US8003684B2 (en) * | 2006-02-21 | 2011-08-23 | Cornerstone Therapeutics, Inc. | Crystal form and pharmaceutical compositions of (+)-R-zileuton |
| WO2008106081A1 (en) * | 2007-02-26 | 2008-09-04 | Larry Schlesinger | Topical formulations containing leukotriene receptor antagonist and use for treatment or prevention of capsular contracture, scarring or hyperpigmentation |
| CN102988276B (en) * | 2011-09-08 | 2015-09-09 | 哈药集团生物工程有限公司 | A kind of Terbinafine hydrochloride emulsifiable paste prescription and preparation technology thereof |
| GB201118193D0 (en) * | 2011-10-21 | 2011-12-07 | Jagotec Ag | Improvements in or relating to oranic compounds |
| CN203126976U (en) * | 2013-01-07 | 2013-08-14 | 浙江吉利汽车研究院有限公司杭州分公司 | Automobile engine hood inner plate |
-
2013
- 2013-10-30 KR KR1020130130165A patent/KR101462474B1/en active IP Right Grant
-
2014
- 2014-08-13 CA CA2907060A patent/CA2907060C/en active Active
- 2014-08-13 BR BR112016009777-7A patent/BR112016009777B1/en active IP Right Grant
- 2014-08-13 ES ES14858248.9T patent/ES2688469T3/en active Active
- 2014-08-13 JP JP2016525982A patent/JP6159885B2/en active Active
- 2014-08-13 SG SG11201602888SA patent/SG11201602888SA/en unknown
- 2014-08-13 US US14/777,183 patent/US9655841B2/en active Active
- 2014-08-13 HU HUE14858248A patent/HUE039408T2/en unknown
- 2014-08-13 RU RU2016114076A patent/RU2616254C1/en active
- 2014-08-13 EP EP14858248.9A patent/EP3064197B1/en active Active
- 2014-08-13 AU AU2014341014A patent/AU2014341014B2/en active Active
- 2014-08-13 CN CN201480057004.1A patent/CN105658202B/en active Active
- 2014-08-13 WO PCT/KR2014/007525 patent/WO2015064898A1/en active Application Filing
- 2014-08-13 DK DK14858248.9T patent/DK3064197T3/en active
-
2016
- 2016-04-19 PH PH12016500726A patent/PH12016500726A1/en unknown
- 2016-10-18 HK HK16111994.5A patent/HK1223568A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2907060C (en) | 2020-08-25 |
| US9655841B2 (en) | 2017-05-23 |
| AU2014341014A1 (en) | 2016-04-21 |
| HK1223568A1 (en) | 2017-08-04 |
| JP6159885B2 (en) | 2017-07-05 |
| JP2016534079A (en) | 2016-11-04 |
| PH12016500726B1 (en) | 2016-05-30 |
| EP3064197A4 (en) | 2017-04-26 |
| EP3064197A1 (en) | 2016-09-07 |
| HUE039408T2 (en) | 2018-12-28 |
| EP3064197B1 (en) | 2018-08-08 |
| CN105658202A (en) | 2016-06-08 |
| ES2688469T3 (en) | 2018-11-02 |
| PH12016500726A1 (en) | 2016-05-30 |
| CA2907060A1 (en) | 2015-05-07 |
| WO2015064898A1 (en) | 2015-05-07 |
| BR112016009777B1 (en) | 2023-02-23 |
| AU2014341014B2 (en) | 2016-12-15 |
| KR101462474B1 (en) | 2014-11-19 |
| US20160228353A1 (en) | 2016-08-11 |
| CN105658202B (en) | 2019-09-13 |
| RU2616254C1 (en) | 2017-04-13 |
| DK3064197T3 (en) | 2018-10-08 |
| BR112016009777A2 (en) | 2017-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3030262T3 (en) | Combined pharmaceutical composition | |
| GB201309406D0 (en) | Topical composition | |
| EP3087987A4 (en) | Pharmaceutical composition containing palonosetron | |
| EP3040077A4 (en) | Traditional chinese medicine composition | |
| EP2990039A4 (en) | Solid pharmaceutical composition | |
| HK1231390A1 (en) | Pharmaceutical composition for topical administration | |
| EP3003324A4 (en) | Pharmaceutical compositions | |
| GB201320932D0 (en) | Topical pharmaceutical composition | |
| HK1223568A1 (en) | Topical anti-inflammatory pharmaceutical composition with zileuton cream formulation | |
| SG11201601477VA (en) | Pharmaceutical composition | |
| HK1219691A1 (en) | Pharmaceutical composition and uses thereof | |
| GB201502845D0 (en) | Topical pharmaceutical formulation | |
| PL2961481T3 (en) | Topical antimicrobial dermatological composition | |
| HK1213813A1 (en) | Icotinib-containing topical skin pharmaceutical compositions and uses thereof | |
| ZA201603604B (en) | Topical pharmaceutical composition of acitretin | |
| HUP1300496A2 (en) | Stable pharmaceutical composition | |
| HK1220143A1 (en) | Pharmaceutical composition | |
| EP2983717A4 (en) | Topical nutraceutical composition | |
| PT2992874T (en) | Liposome for topical administration and application thereof | |
| GB201609968D0 (en) | Topical pharmaceutical formulation | |
| EP3082783A4 (en) | Stable oral pharmaceutical composition | |
| EP2992890A4 (en) | Pharmaceutical composition | |
| GB201319762D0 (en) | Tulathromycin and nonsteroidal anti-inflammatory drug compositions | |
| GB201316498D0 (en) | Topical Pharmaceutical formulation | |
| AU2013903813A0 (en) | Pharmaceutical composition |